Molecular Biology of the Cell by Bruce Alberts, Alexander Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter by by Bruce Alberts, Alexander Johnson, Julian Lewis, David Morg

at any moment to deliver its payload’ and act as ‘biosensors’. The
synthetic substance had ‘the ability to accumulate data from your
body like your breathing, your respiration, thoughts and emotions,
all kind of things’ and each syringe could carry a million nanobots:
This substance because it’s like little bits of computers in your body, crazy, but it’s true, it can
do that, [and] obviously has the ability to act through Wi-Fi. It can receive and transmit
energy, messages, frequencies or impulses. That issue has never been addressed by these
companies. What does that do to the human?
Just imagine getting this substance in you and it can react to things all around you, the 5G,
your smart device, your phones, what is happening with that? What if something is triggering
it, too, like an impulse, a frequency? We have something completely foreign in the human
body.
Madej said her research revealed that electromagnetic (EMF)
frequencies emi ed by phones and other devices had increased
dramatically in the same period of the ‘vaccine’ rollout and she was
seeing more people with radiation problems as 5G and other
electromagnetic technology was expanded and introduced to schools
and hospitals. She said she was ‘floored with the EMF coming off’
the devices she checked. All this makes total sense and syncs with
my own work of decades when you think that Moderna refers in
documents to its mRNA ‘vaccine’ as an ‘operating system’:
Recognizing the broad potential of mRNA science, we set out to create an mRNA technology
platform that functions very much like an operating system on a computer. It is designed so
that it can plug and play interchangeably with different programs. In our case, the ‘program’
or ‘app’ is our mRNA drug – the unique mRNA sequence that codes for a protein …
… Our MRNA Medicines – ‘The ‘Software Of Life’: When we have a concept for a new
mRNA medicine and begin research, fundamental components are already in place.
Generally, the only thing that changes from one potential mRNA medicine to another is the
coding region – the actual genetic code that instructs ribosomes to make protein. Utilizing
these instruction sets gives our investigational mRNA medicines a software-like quality. We
also have the ability to combine different mRNA sequences encoding for different proteins in
a single mRNA investigational medicine.